« Back
Home /
MDX-1342 Biosimilar - Research Grade

MDX-1342 Biosimilar - Research Grade

Manufacturer	IchorBio
Category	Antibodies In Vivo Antibodies
Type	Biosimilars
Specific against	Human
Applications	FA
Amount	20mg
Item no.	ICH5018-20MG
Targets	CD19
eClass 6.1	32160702
eClass 9.0	42030590
Available
Application Notes	This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Background	RUO MDX-1342 a fully human monoclonal antibody, has demonstrated to specifically bind to human CD19 antigen with high affinity. Therefore, it is theorized that MDX-1342 will block activation of B cell stimulation, decreasing the number of cancerous B cell clones.
Concentration	5mg/ml
Endotoxin	≤ 1.0 EU/mg as determined by the LAL method
Formulation	Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purification method	This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Storage	This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Use	Products are for research use only. Not for use in diagnostic or therapeutic procedures.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 20mg

available

Delivery expected until 6/6/2024